Published in World J Surg on April 01, 2013
Curative-intent surgery for hilar cholangiocarcinoma: prognostic factors for clinical decision making. Langenbecks Arch Surg (2014) 0.97
Hilar cholangiocarcinoma: controversies on the extent of surgical resection aiming at cure. Int J Colorectal Dis (2014) 0.88
The Surgical Management of Klatskin Tumours: Has Anything Changed in the Last Decade? World J Surg (2015) 0.78
Actual Long-Term Survival Outcome of 403 Consecutive Patients with Hilar Cholangiocarcinoma. World J Surg (2016) 0.77
Individualized preoperative planning using three-dimensional modeling for Bismuth and Corlette type III hilar cholangiocarcinoma. World J Surg Oncol (2016) 0.75
Surgical treatment of perihilar cholangiocarcinoma: early results of en bloc portal vein resection. Langenbecks Arch Surg (2016) 0.75
The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg (2009) 16.82
Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg (2001) 5.94
Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg (1996) 5.42
ADENOCARCINOMA OF THE HEPATIC DUCT AT ITS BIFURCATION WITHIN THE PORTA HEPATIS. AN UNUSUAL TUMOR WITH DISTINCTIVE CLINICAL AND PATHOLOGICAL FEATURES. Am J Med (1965) 4.22
Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg Gynecol Obstet (1975) 4.17
Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg (2007) 3.73
Portal vein embolization before right hepatectomy: prospective clinical trial. Ann Surg (2003) 3.16
Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization. Ann Surg (2003) 2.04
Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate. Ann Surg (2003) 2.00
Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence. Ann Surg (2008) 1.99
Forty consecutive resections of hilar cholangiocarcinoma with no postoperative mortality and no positive ductal margins: results of a prospective study. Ann Surg (2004) 1.99
The pattern of infiltration at the proximal border of hilar bile duct carcinoma: a histologic analysis of 62 resected cases. Ann Surg (1998) 1.90
Proximal bile duct cancer: high resectability rate and 5-year survival. Ann Surg (1999) 1.83
Improved outcome of resection of hilar cholangiocarcinoma (Klatskin tumor). Ann Surg Oncol (2006) 1.78
Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up. Ann Surg (2006) 1.76
Hilar cholangiocarcinoma: current management. Ann Surg (2009) 1.51
Surgical management of proximal bile duct cancer: extended right lobe resection increases resectability and radicality. Langenbecks Arch Surg (2003) 1.48
Aggressive surgical approaches to hilar cholangiocarcinoma: hepatic or local resection? Surgery (1998) 1.47
Surgical treatment of hilar cholangiocarcinoma in the "new era": the Nagoya University experience. J Hepatobiliary Pancreat Sci (2009) 1.44
Total and segmental liver volume variations: implications for liver surgery. Surgery (2004) 1.41
Role of caudate lobectomy in type III A and III B hilar cholangiocarcinoma: a 15-year experience in a tertiary institution. World J Surg (2012) 1.23
Clinical value of additional resection of a margin-positive proximal bile duct in hilar cholangiocarcinoma. Surgery (2009) 1.10
Aggressive surgical resection for hilar cholangiocarcinoma of the left-side predominance: radicality and safety of left-sided hepatectomy. Ann Surg (2010) 1.06
Long-term survival in hilar cholangiocarcinoma also possible in unresectable patients. World J Surg (2012) 1.04
Surgical approach to bismuth Type I and II hilar cholangiocarcinomas: audit of 54 consecutive cases. Ann Surg (2007) 1.03
Aggressive surgical resection for hilar cholangiocarcinoma: is it justified? Audit of a single center's experience. Am J Surg (2008) 1.02
Improved outcomes after aggressive surgical resection of hilar cholangiocarcinoma: a critical analysis of recurrence and survival. Am J Surg (2011) 0.96
The infiltration of bile duct carcinoma along the bile duct wall. Int Surg (1988) 0.94
Invasive growth patterns of hepatic hilar ductal carcinoma. A histologic analysis of 18 surgical cases. Cancer (1994) 0.90
Surgical pathology of cholangiocarcinoma of the liver hilus (Klatskin tumor). Semin Liver Dis (1990) 0.89
Surgical resection for hilar cholangiocarcinoma: experience improves resectability. HPB (Oxford) (2011) 0.89
Radical surgery for hilar cholangiocarcinoma. Eur J Surg Oncol (2007) 0.88
Evolution of the surgical management of perihilar cholangiocarcinoma in a Western centre demonstrates improved survival with endoscopic biliary drainage and reduced use of blood transfusion. HPB (Oxford) (2011) 0.86
Segments I and IV resection as a new approach for hepatic hilar cholangiocarcinoma. Am J Surg (1998) 0.84
Recent advance in the treatment of hilar cholangiocarcinoma: hepatectomy with vascular resection. J Hepatobiliary Pancreat Surg (2007) 0.82
S4a + S5 with caudate lobe (S1) resection using the Taj Mahal liver parenchymal resection for carcinoma of the biliary tract. J Gastrointest Surg (2000) 0.82
Accurate estimation of living donor right hemi-liver volume from portal vein diameter measurement and standard liver volume calculation. Am J Transplant (2012) 0.80
Experience of surgical resection for hilar cholangiocarcinomas at a Japanese single cancer institute. Hepatogastroenterology (2012) 0.77
Role of hilar resection in the treatment of hilar cholangiocarcinoma. Hepatogastroenterology (2012) 0.76
Recommendations for laparoscopic liver resection: a report from the second international consensus conference held in Morioka. Ann Surg (2015) 2.36
Serous cyst adenoma of the pancreas: appraisal of active surgical strategy before it causes problems. Surg Endosc (2011) 2.19
Comparative study of resection and radiofrequency ablation in the treatment of solitary colorectal liver metastases. Am J Surg (2008) 2.09
Multicenter analysis of clinicopathologic features of intraductal papillary mucinous tumor of the pancreas: is it possible to predict the malignancy before surgery? Ann Surg Oncol (2005) 1.95
Persistent hepatitis B viral replication affects recurrence of hepatocellular carcinoma after curative resection. Liver Int (2007) 1.80
Robotic total mesorectal excision for rectal cancer using four robotic arms. Surg Endosc (2007) 1.68
Human hepatocellular carcinomas with "Stemness"-related marker expression: keratin 19 expression and a poor prognosis. Hepatology (2011) 1.67
Dynamic regulation of CFTR bicarbonate permeability by [Cl-]i and its role in pancreatic bicarbonate secretion. Gastroenterology (2010) 1.58
Quantitative assessment of hTERT mRNA expression in dysplastic nodules of HBV-related hepatocarcinogenesis. Am J Gastroenterol (2006) 1.48
[Assessment of the definition of early extrahepatic bile duct cancer through the prognosis analysis who had received curative resection]. Korean J Gastroenterol (2007) 1.43
MRI features of hepatocellular carcinoma expressing progenitor cell markers. Liver Int (2011) 1.42
Current status of liver diseases in Korea: hepatocellular carcinoma. Korean J Hepatol (2009) 1.42
Conventional laparoscopic and robot-assisted spleen-preserving pancreatectomy: does da Vinci have clinical advantages? Surg Endosc (2010) 1.39
Choledochal cyst and associated malignant tumors in adults: a multicenter survey in South Korea. Arch Surg (2011) 1.33
Solid pseudopapillary tumor of the pancreas suggesting malignant potential. Pancreas (2006) 1.31
Aberrant CpG island hypermethylation in dysplastic nodules and early HCC of hepatitis B virus-related human multistep hepatocarcinogenesis. J Hepatol (2010) 1.30
The use of adjusted preoperative CA 19-9 to predict the recurrence of resectable pancreatic cancer. J Surg Res (2007) 1.28
Outcome after curative resection for a huge (>or=10 cm) hepatocellular carcinoma and prognostic significance of gross tumor classification. Am J Surg (2009) 1.26
Treatment guidelines for branch duct type intraductal papillary mucinous neoplasms of the pancreas: when can we operate or observe? Ann Surg Oncol (2007) 1.24
Clinical validation and risk factors for delayed gastric emptying based on the International Study Group of Pancreatic Surgery (ISGPS) Classification. Surgery (2009) 1.23
Transumbilical single port laparoscopic adrenalectomy: a technical report on right and left adrenalectomy using the glove port. Yonsei Med J (2012) 1.20
Ten years of experience with resection of left-sided pancreatic ductal adenocarcinoma: evolution and initial experience to a laparoscopic approach. Surg Endosc (2010) 1.17
Early experiences of robotic-assisted laparoscopic liver resection. Yonsei Med J (2008) 1.13
Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer. J Gastroenterol Hepatol (2006) 1.12
Robotic liver resection: technique and results of 30 consecutive procedures. Surg Endosc (2012) 1.11
What is the best treatment modality for adrenal metastasis from hepatocellular carcinoma? J Surg Oncol (2007) 1.11
Patterns and relevant factors of tumor recurrence for extrahepatic bile duct carcinoma after radical resection. Hepatogastroenterology (2004) 1.10
Usefulness of 18F-FDG PET in intrahepatic cholangiocarcinoma. Eur J Nucl Med Mol Imaging (2003) 1.10
The effect on porcine bile duct of a metallic stent covered with a paclitaxel-incorporated membrane. Gastrointest Endosc (2005) 1.09
Surgical outcomes of hepatocellular carcinoma with bile duct tumor thrombus: a Korean multicenter study. World J Surg (2013) 1.08
The first korean experience of telemanipulative robot-assisted laparoscopic cholecystectomy using the da vinci system. Yonsei Med J (2007) 1.06
Clinicopathological characteristics in combined hepatocellular-cholangiocarcinoma: a single center study in Korea. Yonsei Med J (2011) 1.05
Insulin-secreting cells from human eyelid-derived stem cells alleviate type I diabetes in immunocompetent mice. Stem Cells (2009) 1.05
A case of primary bilateral adrenal lymphoma (PAL) with central nervous system (CNS) involvement. Yonsei Med J (2002) 1.04
Robotic radical hysterectomy with pelvic lymphadenectomy for cervical carcinoma: a pilot study. Gynecol Oncol (2007) 1.04
Inflammatory pseudotumor of the liver treated by hepatic resection: a case report. Yonsei Med J (2006) 1.04
Factors influencing recurrence after curative resection for ampulla of Vater carcinoma. J Surg Oncol (2007) 1.04
Notch1 differentially regulates oncogenesis by wildtype p53 overexpression and p53 mutation in grade III hepatocellular carcinoma. Hepatology (2011) 1.04
Potential contribution of preoperative neoadjuvant concurrent chemoradiation therapy on margin-negative resection in borderline resectable pancreatic cancer. J Gastrointest Surg (2011) 1.03
Metastatic renal cell carcinoma of the gallbladder. Yonsei Med J (2003) 1.03
Prognostic value of the 7th edition of the AJCC staging system as a clinical staging system in patients with hepatocellular carcinoma. Eur J Cancer (2011) 1.03
Differential diagnosis between gallbladder adenomas and cholesterol polyps on contrast-enhanced harmonic endoscopic ultrasonography. Surg Endosc (2012) 1.03
Transoral robotic surgery (TORS) in laryngeal and hypopharyngeal cancer. J Laparoendosc Adv Surg Tech A (2009) 1.03
The survival outcome and prognostic factors for middle and distal bile duct cancer following surgical resection. J Surg Oncol (2009) 1.02
Prediction of microvascular invasion before curative resection of hepatocellular carcinoma. J Surg Oncol (2008) 1.02
Laparoscopic cholecystectomy for treatment of unexpected early-stage gallbladder cancer. J Surg Oncol (2005) 1.02
Initial experiences using robot-assisted central pancreatectomy with pancreaticogastrostomy: a potential way to advanced laparoscopic pancreatectomy. Surg Endosc (2010) 1.01
Laparoscopic major liver resection in Korea: a multicenter study. J Hepatobiliary Pancreat Sci (2013) 1.01
Analysis of gene expression profiles of hepatocellular carcinomas with regard to 18F-fluorodeoxyglucose uptake pattern on positron emission tomography. Eur J Nucl Med Mol Imaging (2004) 1.01
Percutaneous transhepatic cyst drainage as a "bridge procedure" to definitive treatment of perforated choledochal cysts: a case report. Surg Laparosc Endosc Percutan Tech (2008) 1.00
Prediction of postoperative hepatic insufficiency by liver stiffness measurement (FibroScan((R))) before curative resection of hepatocellular carcinoma: a pilot study. Hepatol Int (2008) 1.00
A case of robot-assisted excision of choledochal cyst, hepaticojejunostomy, and extracorporeal Roux-en-y anastomosis using the da Vinci surgical system. Surg Laparosc Endosc Percutan Tech (2007) 1.00
[Mucinous cholangiocarcinoma associated with Clonorchis sinensis infestation: a case report]. Korean J Hepatol (2004) 1.00
Gallbladder carcinoma associated with anomalous pancreaticobiliary duct junction. Can J Gastroenterol (2007) 1.00
Serum kisspeptin levels in Korean girls with central precocious puberty. J Korean Med Sci (2011) 0.99
What are 'true normal' liver stiffness values using FibroScan?: a prospective study in healthy living liver and kidney donors in South Korea. Liver Int (2009) 0.99
Hepatocellular carcinoma during pregnancy: is hepatocellular carcinoma more aggressive in pregnant patients? J Hepatobiliary Pancreat Sci (2011) 0.98